Literature DB >> 15925275

Unexpected results from the application of signature-tagged mutagenesis to identify Yersinia pestis genes required for adherence and invasion.

S A Leigh1, S Forman, R D Perry, S C Straley.   

Abstract

The signature-tagged mutagenesis (STM) method was applied in a protocol designed to identify genes required for Yersinia pestis invasion into epithelial cells. A library of 3060 mutants of Y. pestis CO99-3015 was made and assayed using an in vitro invasion assay with gentamicin protection. Initial results from the screen identified a set of 23 genes that might be required for invasion; however, screening of individual mutants for decreased invasion, even in a competition assay with the parent strain, failed to reveal obvious invasion defects. Altered colony character or size might have imposed a growth disadvantage for two of the mutants, which could possibly account for apparently decreased invasion. The sensitivity of the mutants to gentamicin was assayed to determine if the presence of the kanamycin-resistance cassette in the STM transposon changed the gentamicin resistance of the individual mutants. It was discovered that the mutants exhibited a variable range of resistance to killing by gentamicin, suggesting that the presence of the kanamycin-resistance cassette or the particular insertion mutation did in many cases affect the bactericidal potency of gentamicin. However, all mutants remained highly sensitive to growth inhibition in a disk assay on plates. These results may warrant precautions for use of kanamycin-resistance markers in studies with fully virulent Y. pestis, since gentamicin has been recommended for treatment of plague. Further, to use STM in the context of invasion assays, a selection other than gentamicin should be applied.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925275     DOI: 10.1016/j.micpath.2005.02.004

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  6 in total

1.  yadBC of Yersinia pestis, a new virulence determinant for bubonic plague.

Authors:  Stanislav Forman; Christine R Wulff; Tanya Myers-Morales; Clarissa Cowan; Robert D Perry; Susan C Straley
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

2.  High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.

Authors:  Duraisamy Ponnusamy; Eric C Fitts; Jian Sha; Tatiana E Erova; Elena V Kozlova; Michelle L Kirtley; Bethany L Tiner; Jourdan A Andersson; Ashok K Chopra
Journal:  Infect Immun       Date:  2015-03-09       Impact factor: 3.441

3.  High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay.

Authors:  Bei Li; Lei Zhou; JingYu Guo; Xiaoyi Wang; Bin Ni; Yuehua Ke; Ziwen Zhu; Zhaobiao Guo; Ruifu Yang
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

4.  Poly-N-acetylglucosamine expression by wild-type Yersinia pestis is maximal at mammalian, not flea, temperatures.

Authors:  Pauline Yoong; Colette Cywes-Bentley; Gerald B Pier
Journal:  mBio       Date:  2012-08-14       Impact factor: 7.867

Review 5.  Yersinia pestis: mechanisms of entry into and resistance to the host cell.

Authors:  Yuehua Ke; Zeliang Chen; Ruifu Yang
Journal:  Front Cell Infect Microbiol       Date:  2013-12-24       Impact factor: 5.293

6.  Impact of Gentamicin Concentration and Exposure Time on Intracellular Yersinia pestis.

Authors:  Tiva T VanCleave; Amanda R Pulsifer; Michael G Connor; Jonathan M Warawa; Matthew B Lawrenz
Journal:  Front Cell Infect Microbiol       Date:  2017-12-11       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.